Medindia

X

Clinical Trials of Ixekizumab Offers New Hope to Many Patients with Psoriasis

by Dr. Trupti Shirole on  June 15, 2015 at 11:08 AM Drug News   - G J E 4
Psoriasis is characterized by an abundance of skin cells that causes raised bumps known as 'plaques' to grow on the skin. These plaques can be flaky, scaly and itchy for sufferers. Clinical trials of a new drug ixekizumab has revealed that almost 40% of participants showed complete clearance of their plaques, while 90% experienced some improvement.
Clinical Trials of Ixekizumab Offers New Hope to Many Patients with Psoriasis
Clinical Trials of Ixekizumab Offers New Hope to Many Patients with Psoriasis
Advertisement

Researchers at the University of Manchester tested the effectiveness of the drug ixekizumab. Half of the study participants were given the new drug, ixekizumab while the other half were given a placebo, or a widely used drug for psoriasis called etanercept. The ixekizumab group showed quick and extensive improvements in their skin condition, outperforming the groups on placebo or etanercept. Around 50% of these patients showed improvement as early as week four of the trial and up to 71% had shown a high level of improvement in their symptoms.

Advertisement
Source: ANI
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All